TY - CHAP M1 - Book, Section TI - Dermal Fillers A1 - Heitmiller, Kerry A1 - Saedi, Nazanin A2 - Baumann, Leslie S. A2 - Rieder, Evan A. A2 - Sun, Mary D. Y1 - 2022 N1 - T2 - Baumann’s Cosmetic Dermatology, 3e AB - SUMMARY POINTSThe dermal filler market is rapidly growing worldwide, and several innovations have led to a parallel expansion in product variety.Currently, a variety of dermal fillers are available for use including temporary fillers (i.e., hyaluronic acid fillers), semi-permanent fillers (i.e., calcium hydroxylapatite and poly-L-lactic acid), and permanent fillers (i.e., polymethylmethacrylate, silicone, autologous fat). Hyaluronic acid fillers are the most frequently used for soft tissue augmentation.It is important for the aesthetic practitioner to understand the unique physicochemical and rheological properties of the available dermal fillers to achieve optimal cosmetic outcomes. Additionally, the aesthetic practitioner should be well educated on any potential adverse effects and complications associated with soft tissue filler injection, so that they can be prevented or treated appropriately should they arise.Pre-procedural patient assessment including a discussion of appropriate expectations and potential adverse events is critical prior to treatment with dermal fillers.Newer hyaluronic acid products have been developed recently, specifically, a collection of fillers uniquely designed to be more flexible and to more closely resemble naturally occurring hyaluronic acid, indicated for dynamic wrinkles and folds with less reactivity.Research is ongoing to develop filler products that address the shortcomings of the earlier products while incorporating and expanding on their advantages. Additional hyaluronic acid products, combination hyaluronic acid-calcium hydroxylapatite products, and a number of novel filler products are currently in development.To keep astride with the rapidly changing cosmetic dermatology arena, it behooves the aesthetic practitioner to be aware of the current availability, application, and future potential of dermal fillers. SN - PB - McGraw Hill LLC CY - New York, NY Y2 - 2024/03/29 UR - dermatology.mhmedical.com/content.aspx?aid=1197534550 ER -